drugset / Trial / NCT05691894

Tracer Targeting FAP PET Imaging in Patients

NCT05691894

Phase 0 Unknown 20 enrolled Affiliated Hospital of Jiangnan University
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

This is a single arm study to evaluate the safety and biodistribution of tracer targeting FAP PET Imaging in patients

Timeline

Start
2022-11-02
Primary completion
2023-11
Completion
2023-11

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-FAPI Diagnostic / imaging agent 8 unknown
Subject 18F-FAPI Diagnostic / imaging agent 10 unknown
Subject FAPI GA-68 Diagnostic / imaging agent 2 unknown
Subject FAPI GA-68 Diagnostic / imaging agent 5 unknown

Indications